EP4243762A1 - Émulsion contenant de la gomme de ceratonia siliqua et des chlorhydrates d'aluminium - Google Patents

Émulsion contenant de la gomme de ceratonia siliqua et des chlorhydrates d'aluminium

Info

Publication number
EP4243762A1
EP4243762A1 EP21798388.1A EP21798388A EP4243762A1 EP 4243762 A1 EP4243762 A1 EP 4243762A1 EP 21798388 A EP21798388 A EP 21798388A EP 4243762 A1 EP4243762 A1 EP 4243762A1
Authority
EP
European Patent Office
Prior art keywords
weight
preparation
polyglyceryl
preparation according
proportion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21798388.1A
Other languages
German (de)
English (en)
Inventor
Anabelle von Davier
Robert Klauck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of EP4243762A1 publication Critical patent/EP4243762A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients

Definitions

  • the invention belongs to the cosmetic field and relates to an antiperspirant cosmetic preparation which is present as an emulsion.
  • cosmetic products not only serve to look beautiful and attractive, but with their effect they make a decisive contribution to increased self-esteem and the well-being of people. Accordingly, a wide variety of cosmetic products are used for the daily cleansing and care of the skin.
  • deodorants and antiperspirants which are used under the armpits to prevent bad smells.
  • the cause of bad odors is the decomposition of per se odorless sweat by bacteria. Fatty acid residues occur as a product of the decomposition, which characterize the typically known smell of sweat. Regardless of the fact that deodorants and antiperspirants are used on the same area of skin and have the same objective, they differ in their technical effect.
  • Antiperspirants contain antiperspirant active ingredients that serve to impede and reduce the flow of sweat. Aluminum-containing antiperspirant active ingredients clog the sweat glands.
  • Deodorants are characterized in that they do not prevent the flow of sweat. Instead, deodorants are products that contain special antimicrobial agents that reduce the growth of bacteria such as Corynebacterium jeikeium or Staphylococcus epidermidis. Consequently, the decomposition of the odorless sweat is reduced, so that less malodor occurs.
  • antiperspirants and deodorants are applied to the skin either by means of an application roller or as a spray.
  • Both propellant-operated aerosol sprays and those operated by means of a hand pump come as sprays Pump sprays used.
  • the composition of the cosmetic preparations varies significantly.
  • a known form of antiperspirant preparations for application using a roll-on applicator are (macro) emulsions.
  • these usually contain emulsifiers which have at least one polyethylene glycol (PEG) subunit.
  • PEG polyethylene glycol
  • a popular emulsifier combination is Steareth-21 and Steareth-2.
  • the emulsifiers serve to prevent phase separation of the oil and water phases of the emulsion.
  • an aqueous phase and an oil phase a preparation is obtained which has a milky appearance. This appearance is particularly popular with consumers, since a white, creamy preparation is always associated with an increased care effect for the skin.
  • Known formulations according to the above description result, inter alia, from EP 2023888 A1.
  • polymers such as hydroxyethyl cellulose do not belong in the biopolymer category, as this is a chemically modified polymer.
  • a well known biologically occurring polymer is xanthan gum.
  • xanthan gum is unsuitable for PEG-free emulsions containing an aluminum-containing antiperspirant active ingredient, since precipitation occurs when used in combination in the preparations.
  • the present invention was able to address the disadvantages of the prior art.
  • the subject matter of the present invention is a cosmetic preparation in the form of an emulsion containing a) at least one aluminum-containing antiperspirant active ingredient, and b) Ceratonia Siliqua Gum, characterized in that the preparation is free from substances which have a polyethylene glycol subunit.
  • Another object of the invention is the use of Ceratonia Siliqua Gum in a cosmetic preparation in the form of an emulsion containing an aluminum-containing antiperspirant active ingredient to stabilize the emulsion, the preparation being free of substances which have a polyethylene glycol subunit.
  • stabilization is understood as preventing and/or reducing the formation of precipitates in the emulsion.
  • normal conditions / normal conditions refers to 20 ° C, 1013 hPa and a relative humidity of 50%.
  • skin refers exclusively to human skin. If viscosity values are given in this disclosure, then all values relate to a measurement at 25° C. in a 150 ml wide-mouth bottle (VWR No.: 807-001) using Rheomat R 123 from the company proRheo.
  • the Rheomat R 123 from proRheo GmbH is a rotational viscometer, ie a measuring body rotates in the substance to be measured. The force required to rotate the measuring body in the sample at a specified speed is measured. The viscosity is calculated from this torque, the speed of the measuring body and the geometric dimensions of the measuring system used. Measuring body No. 1 (item no. 200 0191), suitable for a viscosity range of up to 10,000 [mPa s], speed range 62.5 rpm, is used as the measuring body.
  • the preparation according to the invention was surprisingly able to eliminate or reduce the disadvantages of the prior art.
  • no precipitation occurred with the mixture of Ceratonia Siliqua Gum with aluminum-containing antiperspirant active ingredient and a stable product could be provided in which a biopolymer is used as the polymer.
  • the preparation of the present invention is advantageously characterized in that it is in the form of an oil-in-water emulsion.
  • the preparation contains at least one aluminum-containing antiperspirant active ingredient.
  • Examples of aluminum salts according to the invention are:
  • Aluminum salts such as aluminum chloride AlC, aluminum sulphate Ah(SO4)3
  • At least one aluminum zirconium salt is present as the antiperspirant active ingredient.
  • These are advantageously selected from the group of aluminium/zirconium trichlorohydrex glycine ([Al4Zr(OH)i3Cls] x H2O x Gly), aluminium/zirconium tetrachlorohydrex glycine ([Al4Zr(OH)i2Cl4] x H2O x Gly), aluminium/zirconium pentachlorohydrex glycine ([Al8Zr(OH)2sCl5] x H2O x Gly), aluminum/zirconium octachlorohydrex glycine ([Al8Zr(OH)2oCls] x H2O x Gly) and the glycine-free aluminum/zirconium salts.
  • Aluminum/zirconium tetrachlorohydrex glycine is particularly preferred.
  • the proportion of the aluminum-containing antiperspirant active ingredient is advantageously from 2.5% by weight to 20% by weight, preferably from 5% by weight to 17.5% by weight and particularly preferably from 7.5% by weight to 15% by weight % by weight, based on the total weight of the preparation.
  • the proportion of aluminum chlorohydrate is from 2.5% by weight to 20% by weight, preferably from 5% by weight to 17.5% by weight and particularly preferably from 7.5% by weight. is up to 15% by weight, based on the total weight of the preparation.
  • the preparation according to the invention comprises Ceratonia Siliqua Gum. It is advantageous if the proportion of Ceratonia Siliqua Gum is from 0.1 to 1.0% by weight, preferably from 0.15 to 0.7% by weight and in particular 0.2 to 0.55% by weight. % is based on the total weight of the preparation.
  • the preparation according to the invention preferably contains at least one emulsifier which has no polyethylene glycol subunit.
  • a polyethylene glycol subunit consists of at least 2 consecutive ethylene glycol units.
  • emulsifiers and/or emulsifier combinations enable effective stabilization of the preparations according to the invention. It was surprisingly found that the specific use of emulsifiers preferred according to the invention means that water does not separate out when stored at temperatures of 40° C. or occurs only later and/or the preparation does not become gritty when stored.
  • anionic emulsifier it is advantageous if at least one anionic emulsifier is present as the emulsifier.
  • anionic emulsifiers sodium stearoyl glutamate is particularly preferred. If sodium stearoyl glutamate is present, it is advantageous if the proportion of sodium stearoyl glutamate is from 0.1 to 4% by weight, preferably from 0.2 to 2.5% by weight and particularly preferably 0.3% by weight. % to 0.5% by weight, based on the total weight of the preparation.
  • glyceryl stearate citrate is also included. If glyceryl stearate citrate is present, the proportion of glyceryl stearate citrate is advantageously from 0.5 to 6% by weight, preferably from 1.5 to 5% by weight and particularly preferably from 3.5 to 4.5% by weight. -% based on the total weight of the preparation.
  • compositions according to the invention are advantageously characterized in that they contain no glyceryl stearate citrate.
  • Another, even more advantageous combination of emulsifiers results from the combination of sodium stearoyl glutamate and methyl glucose sesquistearate.
  • the proportion of methyl glucose sesquistearate is advantageously from 0.5 to 6% by weight, based on the total weight of the preparation.
  • the proportion of methyl glucose sesquistearate is advantageously from 0.9 to 6% by weight, preferably from 2.8 to 5.5% by weight and particularly preferably from 3 .8 to 5.0% by weight, based on the total weight of the preparation.
  • polyglyceryl esters are understood as meaning an ester which consists of
  • Polyglycerol e.g. polyglycerol-10 and at least one fatty acid is formed.
  • advantageous polyglycerol esters are polyglyceryl-10 caprate, polyglyceryl-10 laurate, polyglyceryl-10 trilaurate, polyglyceryl-10 myristate, polyglyceryl-10 dimyristate, polyglyceryl-10 oleate, polyglyceryl-10 diolate, polyglyceryl-10 stearate, polyglyceryl-10 distearate, polyglyceryl -10 Diisostearate, Polyglyceryl-6 Caprylate, Polyglyceryl-6 Dicaprylate, Polyglyceryl-6 Oleate, Polyglyceryl-6 Ricinoleate, Polyglyceryl-6 Stearate, Polyglyceryl-6 Behenate, Polyglyceryl-5 Laurate, Polyglyceryl-5 Myristate, Polyglyceryl-5 Oleate, Polyglyceryl -5 dioleates, polyglyceryl 5 stearates, polyglyceryl 4 caprates, polyglyceryl 3
  • polyglyceryl ester or polyglyceryl esters are formed from a polyglycerol having 3 to 10 glycerol subunits and at least one fatty acid having 12 to 22 carbon atoms. It is particularly advantageous if the polyglyceryl ester or polyglyceryl esters are formed from a polyglycerol having 6 glycerol subunits and at least one fatty acid having 18 to 22 carbon atoms.
  • Polyglyceryl-10 laurates, polyglyceryl-6 stearates and/or polyglyceryl-6 behenates are particularly preferred.
  • the total proportion of polyglyceryl esters is advantageously from 0.5 to 8.0% by weight, preferably from 1.0 to 6.0% by weight and particularly preferably from 2.0 to 5.5% by weight, based on the total weight of the preparation.
  • the total proportion of the polyglyceryl esters from a polyglycerol with 3 to 10 glycerol subunits and at least one fatty acid having 12 to 22 carbon atoms is advantageously from 0.5 to 8.0% by weight, preferably from 1.0 to 6.0% by weight particularly preferably from 2.0 to 5.5% by weight, based on the total weight of the preparation.
  • the total proportion of the polyglyceryl esters selected from the group of polyglyceryl esters which are advantageous according to the invention is polyglyceryl-10 caprate, polyglyceryl-10 laurate, polyglyceryl-10 trilaurate, polyglyceryl-10 myristate, polyglyceryl-10 dimyristate, polyglyceryl-10 oleate, polyglyceryl-10 dioleate, polyglyceryl -10 stearates, polyglyceryl-10 distearates, polyglyceryl-10 diisostearate, polyglyceryl-6 caprylate, polyglyceryl-6 Dicaprylate, Polyglyceryl-6 Oleate, Polyglyceryl-6 Ricinoleate, Polyglyceryl-6 Stearate, Polyglyceryl-6 Behenate, Polyglyceryl-5 Laurate, Polyglyceryl-5 Myristate, Polyglyceryl-5 Oleate, Polyglyceryl-5 Dioleate, Polyglyceryl-5 Ste
  • the total proportion of the polyglyceryl esters polyglyceryl-10 laurates, polyglyceryl-6 stearates and/or polyglyceryl-6 behenates is advantageously from 0.5 to 8.0% by weight, preferably from 1.0 to 6.0% by weight and in particular preferably from 3.0 to 5.5% by weight based on the total weight of the preparation.
  • the weight ratio of polyglyceryl-6 stearate to polyglyceryl-6 behenate is from 99:1 to 70:30, particularly preferably from 98:1 to 80:20.
  • the weight ratio of the one or more polyglycerol esters to methyl glucose sesquistearate is from 10:1 to 1:1 and in particular from 5:1 to 2:1.
  • polyglyceryl-3 methylglucose distearate is present as an emulsifier. If polyglyceryl-3 methylglucose distearate is present, it is preferred if the proportion of polyglyceryl-3 methylglucose distearate is from 0.5 to 4% by weight, based on the total weight of the preparation.
  • the proportion of sorbitan stearate is preferably from 0.2 to 3% by weight, more preferably from 0.7 to 1.5% by weight, based on the total weight of the preparation.
  • the preparation according to the present invention comprises at least one oil component. It is preferred according to the invention if the preparation contains one or more oils in a total proportion of from 0.5 to 10% by weight, preferably from 1.0% by weight to 8% by weight and particularly preferably from 2.0 to 4% by weight, based on the total weight of the preparation. According to the invention, it is advantageous if at least one natural oil is contained as the oil component.
  • the natural oils are advantageous selected from the group of sunflower oil (Helianthus Annuus Seed Oil), rapeseed oil (Canola Oil), soybean oil (Glycine Soya Oil), olive oil (Olea Europaea Fruit Oil), almond oil (Prunus amygdalus dulcis Oil), avocado oil (Persea gratissima oil), walnut oil (Junglans Regia Seed Oil), peach kernel oil (Prunus Persica Kernel Oil), apricot kernel oil (Prunus Armeniaca Kernel Oil), sesame oil (Sesamum Indicum Seed Oil), camellia oil (Camelia Oleifera/ Camelia Sasanqua), evening primrose oil (Oenothera biennis) , Macadamia Nut Oil (Macadamia Intergrifolia Seed Oil), Safflower Oil (Silybum Marianum Seed Oil), Wheat Germ Oil (Triticum Vulgare Germ Oil), Palm Kernel Oil (Elaeis guineensis Kerna), sunflower oil
  • caprylic/capric triglycerides are present as the oil.
  • caprylic/capric triglycerides have turned out to be surprisingly advantageous with regard to the prevention of water separation in the preparations according to the invention.
  • the total proportion of caprylic/capric triglyceride in the preparation is preferably from 0.6 to 9.9% by weight, preferably from 1.1 to 7.9% by weight and particularly preferably from 2.1 to 5.9% by weight, based on the total weight of the preparation.
  • dicaprylyl ether is contained as an oil. If dicaprylyl ether is present, it is advantageous if the proportion of dicaprylyl ether is from 0.6 to 9.9% by weight, preferably from 1.1 to 7.9% by weight and particularly preferably from 2.0 to 4.0% by weight, based on the total weight of the preparation.
  • the preparation additionally contains at least one or more perfume substances which are liquid under normal conditions.
  • perfumes are selected from essential oils, geraniol, geranyl acetate, linalool, linalyl acetate, tetrahydrolinalool, citronellol, citronellyl acetate, dihydromyrcenol, dihydromyrcenyl acetate, tetrahydromyrcenol, terpineol, terpinyl acetate, nopol, nopyl acetate, 2-phenyl benzyl alcohol, benzyl acetate, benzyl salicylate, benzyl benzoate, styrallyl acetate , amyl salicylate, dimethylbenzyl carbinol, trichloromethylphenylcarbinyl acetate, p-tert-butylcyclohexyl acetate, isononyl
  • the proportion of perfume substances which are liquid under normal conditions is advantageously from 0.001 to 2.0% by weight, preferably from 0.005 to 1.5% by weight and particularly preferably from 0.01 to 1.0% by weight, based on the total weight the preparation.
  • the preparation contains water, it being preferred if the proportion of water is from 60 to 88% by weight, particularly preferably 68 to 85% by weight, the figures relating to the total weight of the preparation relate.
  • the preparation comprises glycerol, the proportion of glycerol advantageously being in the range from 0.5 to 12% by weight, preferably 2 to 11% by weight and particularly preferably in the range from 2.5 to 10.5% by weight, the figures relating to the total weight of the preparation.
  • the preparations can contain further excipients. These can include dyes, deodorants or other ingredients.
  • the preparation according to the invention is advantageously characterized in that it is free from xanthan gum.
  • the preparation according to the invention is advantageously characterized in that it is free from polymers which are obtained from homopolymerization or copolymerization with acrylic acid.
  • the preparation according to the invention is advantageously characterized in that it is free from hydroxyethyl celluse.
  • the preparation according to the invention is advantageously characterized in that it is free from polyurea crosspolymer-2.
  • the preparation can advantageously contain one or more fatty alcohols having 12 to 22 carbon atoms, it being further preferred if the proportion of fatty alcohols having 12 to 22 carbon atoms is from 0.5 to 3% by weight, based on the total weight of the preparation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une préparation cosmétique contenant des ingrédients cosmétiques.
EP21798388.1A 2020-11-16 2021-10-25 Émulsion contenant de la gomme de ceratonia siliqua et des chlorhydrates d'aluminium Pending EP4243762A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102020214353.6A DE102020214353A1 (de) 2020-11-16 2020-11-16 Emulsion enthaltend Ceratonia Siliqua Gum und Aluminium Chlorohydrate
PCT/EP2021/079538 WO2022100994A1 (fr) 2020-11-16 2021-10-25 Émulsion contenant de la gomme de ceratonia siliqua et des chlorhydrates d'aluminium

Publications (1)

Publication Number Publication Date
EP4243762A1 true EP4243762A1 (fr) 2023-09-20

Family

ID=78372041

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21798388.1A Pending EP4243762A1 (fr) 2020-11-16 2021-10-25 Émulsion contenant de la gomme de ceratonia siliqua et des chlorhydrates d'aluminium

Country Status (3)

Country Link
EP (1) EP4243762A1 (fr)
DE (1) DE102020214353A1 (fr)
WO (1) WO2022100994A1 (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7789800A (en) * 1999-10-22 2001-04-30 Unilever Plc Stable multiple emulsion composition
DE102006020382A1 (de) 2006-04-28 2007-10-31 Henkel Kgaa Schnell trocknende kosmetische Emulsionen zur Roll-on-Applikation
DE102007030099A1 (de) 2007-06-28 2009-01-02 Henkel Ag & Co. Kgaa Kosmetische Zusammensetzung enthaltend einen Champagner-Extrakt
DE102008042149A1 (de) 2008-09-17 2010-03-18 Evonik Goldschmidt Gmbh Kosmetische und dermatologische Formulierungen enthaltend Phenoxyalkylester
DE102011089340A1 (de) 2011-12-21 2013-06-27 Henkel Ag & Co. Kgaa PEG-freie Antitranspirant-Öl-in-Wasser-Emulsionen mit verbesserter Haptik
DE102013220767A1 (de) 2013-10-15 2015-04-16 Henkel Ag & Co. Kgaa Verwendung von Polysacchariden in schweißhemmenden kosmetischen Mitteln zur Textilschonung
DE102015225958A1 (de) 2015-12-18 2017-06-22 Henkel Ag & Co. Kgaa Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen
KR102060699B1 (ko) * 2018-10-19 2019-12-30 주식회사 러브바드 신축성 마스크팩용 하이드로겔 조성물 및 이를 함유하는 신축성 마스크팩

Also Published As

Publication number Publication date
WO2022100994A1 (fr) 2022-05-19
DE102020214353A1 (de) 2022-05-19

Similar Documents

Publication Publication Date Title
EP2651521A2 (fr) Compositions anti-transpirantes aqueuses à masquage amélioré des sels résiduels
EP0814753A2 (fr) Gels cosmetiques ou dermatologiques a base de microemulsions
WO2022100992A1 (fr) Pulvérisateur à pompe contenant des sels d'aluminium
EP3209387A1 (fr) Produits cosmétiques anti-transpirants à teneur en chitosan, exempts d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
DE102010034389B4 (de) Stabilisierte W/O-Emulsionen
EP4326220A1 (fr) Préparation cosmétique transparente contenant du polyglycéryl-6 caprate et du polyglycéryl-4 caprate
EP4243762A1 (fr) Émulsion contenant de la gomme de ceratonia siliqua et des chlorhydrates d'aluminium
EP3191078A1 (fr) Produits cosmétiques anti-transpirants contenant des protéines spéciales dérivées de malvacées du genre adansonia, exempts d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
WO2022100991A1 (fr) Émulsion contenant des biopolymères et des chlorohydrates d'aluminium
WO2012167900A2 (fr) Compositions cosmétiques ou dermatologiques sous forme d'émulsions et ayant une libération de parfum améliorée
DE10219189A1 (de) Wasserfreie Antitranspirant-Formulierung in halbfester bis fester Form
JPH06128135A (ja) Ｗ／ｏ型乳化化粧料
WO2003030855A1 (fr) Produit antitranspirant a base de gels en microemulsion
WO2016005243A1 (fr) Agents cosmétiques anti-transpirants avec des protéines spéciales provenant de légumineuses de l'espèce pisum et/ou phaseolus et/ou vigna et/ou macrotyloma ou provenant de crucifères de l'espèce brassica, qui ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
EP4326219A1 (fr) Préparation cosmétique transparente
EP4326221A1 (fr) Préparation cosmétique transparente
WO2024083394A1 (fr) Préparation cosmétique transparente contenant des polyglycéryl-3 caprates/caprylates/succinates
WO2016005199A1 (fr) Produits cosmétiques anti-transpirants comprenant des protéines spéciales issues des légumineuses du genre glycine, lesquelles ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
EP4243761A1 (fr) Pulvérisateur à pompe contenant des substances désodorisantes
EP3166694A1 (fr) Agents cosmétiques anti-transpirants avec des protéines spéciales provenant de graminées de l'espèce triticum et/ou oryza et/ou avena, qui ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
WO2019120664A1 (fr) Préparation topique destinée à améliorer l'hydratation de la peau
WO2022167176A1 (fr) Spray anti-transpirant ayant une tendance réduite à la formation de taches sur les textiles
AU2019393137A1 (en) Emulsifying composition comprising a water-in-oil emulsifier and a cyclodextrin of selected particle size, capable of providing an oil-in-water emulsion with improved sensory effects for cosmetic use
EP3166588A1 (fr) Agents cosmétiques anti-transpirants avec des protéines spéciales provenant de sécrétions animales, de sécrétions d'insectes ou de sécrétions humaines, qui ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
WO2016030045A1 (fr) Produits cosmétiques anti-transpirants contenant des protéines spéciales isolées à partir de bactéries ou de champignons ou d'algues, ne renfermant pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230616

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BEIERSDORF AG